For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
Blog
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time…
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
Search Posts
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News GLOBAL WARMING An article explains the shortcomings of climate impact models. CEI Expert Available to Comment: Director…
News Release
Claims by Energy Security Advocates Clash with Consumer Safety Concerns
Contact: <?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Jody Clarke, 202.331.2252 Washington, D.C., December 19,…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. SCIENCE Researchers suggest a link between climate change and increased rates of malaria infection…
Blog
Draining the Swamp: Reform for Anti-Malaria Policy
The White House is hosting a summit on malaria this week, and our good friend Roger Bate will be attending. And since Roger has…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. HEALTH A new study finds Americans are unsure about the safety of biotech foods.
Op-Eds
Animal cloning no barnyard bijou
There was a time when you would be labeled a right-wing extremist for demanding the Food and Drug Administration base decisions on morality…